Uncategorized

France’s biotech ecosystem: science, capital and scale

Published

on

In this episode of Denatured, as part of our series on the European life sciences investment ecosystem, you’ll be hearing from Ksenija Pavletic, partner and chief commercial officer at Jeito Capital and Thierry Laugel, managing partner at Kurma Partners. We dive into France’s biotech ecosystem and what still needs to happen for more early innovation to translate into investable, scalable biotech.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version